GGrantIndex
← Leaderboards

Aneta Joanna Mieszawska

Brooklyn College

$1,547,051
Attributed
$2,623,101
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $524.3K · FY201523
$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$2,623,101 · 2

By mechanism

R01$2,152,101 · 1
SC2$471,000 · 1

Top collaborators

Most similar at Brooklyn College

Same institution · by research overlap

Others in their field

Top investigators on “Generations

Research focus

GenerationsEvaluationExhibitsFluorophoreEncapsulatedEndotheliumCytotoxicDiagnosticDna RepairDoseDrug ResistanceEffectivenessAntineoplastic AgentsBiologicalCancer RelapseClinical InvestigationDiagnosisCancer TherapyChemotherapyDna DamageCancer CellDosageCancer PatientHalf-Life

Grant awards (13)

Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$323,970
R01 · FY2023 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$323,970
R01 · FY2022 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$118,979
R01 · FY2022 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$330,582
R01 · FY2021 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$121,408
R01 · FY2021 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$72,341
R01 · FY2021 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$330,582
R01 · FY2020 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$121,408
R01 · FY2020 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$66,737
R01 · FY2020 · CA · contact PI
Anti-vascular and cytotoxic nanoparticle formulations for ovarian cancer therapy$342,124
R01 · FY2019 · CA · contact PI
Theranostic nanoparticles for dual modality cancer therapy$157,000
SC2 · FY2017 · CA · contact PI
Theranostic nanoparticles for dual modality cancer therapy$157,000
SC2 · FY2016 · CA · contact PI
Theranostic nanoparticles for dual modality cancer therapy$157,000
SC2 · FY2015 · CA · contact PI